Home / Recalls / Sandoz Inc / D-0262-2019

D-0262-2019 Class III Terminated

Recalled by Sandoz Inc — Princeton, NJ

Recall Details

Product Type
Drugs
Report Date
November 21, 2018
Initiation Date
November 2, 2018
Termination Date
October 2, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
23053 bottles

Product Description

Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals) 100 mg, 100-count bottoles, Rx Only, Manufactured for: Northstar Rx LLC Memphis, TN 38141 Manufactured by: Sandoz Inc. Princeton, NJ 08540,NDC 16714-439-01

Reason for Recall

Cross Contamination with Other Products

Distribution Pattern

Nationwide within the United States

Code Information

Lot #: JA7319, JA 7320, JA7321, Exp. 03/2020

Other recalls by Sandoz Inc

  • D-0651-2025 Class II — Cyclophosphamide Injection 500 mg/5 mL (100 mg/mL), Hazardous Drug, Rx Only, Ste (September 5, 2025)
  • D-0626-2025 Class II — Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension Rx Only, For Use in Ea (August 13, 2025)
  • D-0569-2025 Class I — Cefazolin for Injection, USP, 1 gram per vial, Sterile, For Intramuscular or Int (June 27, 2025)
  • D-0570-2025 Class I — Buffered Penicillin G Potassium for Injection, USP 20,000,000 Units (20 million (June 27, 2025)
  • D-0753-2022 Class II — Orphenadrine Citrate Extended-Release Tablets, USP 100 mg, Rx Only, 100 Tablets, (March 21, 2022)
  • D-0286-2022 Class I — Enoxaparin Sodium Injection, USP, 40 mg/0.4 mL, Single-Dose Syringes with Automa (November 17, 2021)
  • D-1259-2020 Class II — Infuvite PEDiatric Pharmacy, kit in 1 carton (40 mL fill in a 50 mL) vial 1 an (April 21, 2020)
  • D-0162-2020 Class III — Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension, Rx On (October 17, 2019)
  • D-0163-2020 Class III — Gatifloxacin Ophthalmic Solution 0.5%, For Use in the Eyes Only, Rx Only, Steril (October 17, 2019)
  • D-0161-2020 Class III — Bimatoprost Ophthalmic Solution 0.03%, Rx Only, For Topical Application to the U (October 17, 2019)